Back
Day Range
$28.40
$29.80
52-Week Range
$2.99
$41.89
Volume
67,152
50D / 200D Avg
$26.20
/
$17.10
Prev Close
$30.41
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.8 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 586.9 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$26.00
-11.2%
Forward EPS
-$0.28
Est. Revenue
36 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$0.25
-$0.38 – -$0.17
|
41 M | 1 |
| FY2028 |
$0.53
$0.36 – $0.80
|
91 M | 1 |
| FY2027 |
-$0.50
-$0.75 – -$0.34
|
38 M | 1 |
Key Takeaways
Net margin of 586.89% shows strong profitability
Negative free cash flow of -20.40M
Capital efficient — spends only -7.30% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-132.06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin586.89%
Op. Margin589.13%
Safety
Debt / Equity
N/A
Current Ratio1.04
Interest Coverage-8.46
Valuation
P/E Ratio
-20.78
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -132.06% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | -11.61M | Net Income (TTM) | -68.13M |
| ROE | N/A | ROA | -101.06% |
| Gross Margin | 100.00% | Operating Margin | 589.13% |
| Net Margin | 586.89% | Free Cash Flow (TTM) | -20.40M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.04 |
| Interest Coverage | -8.46 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.78 | P/B Ratio | N/A |
| P/S Ratio | -121.98 | PEG Ratio | -0.06 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.42B | Enterprise Value | 1.42B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | -11.61M | 36.21M | 4.78M | 2.65M | 50,000.0 |
| Net Income | -68.13M | -39.70M | -57.04M | -47.00M | -33.62M |
| EPS (Diluted) | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 |
| Gross Profit | -11.61M | 36.21M | 3.79M | 2.65M | 50,000.0 |
| Operating Income | -68.39M | -26.78M | -46.70M | -52.58M | -36.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 67.42M | 93.90M | 59.77M | 101.77M | 134.03M |
| Total Liabilities | 133.12M | 95.74M | 86.81M | 74.98M | 63.56M |
| Shareholders' Equity | -65.70M | -1.84M | -27.05M | 26.79M | 70.47M |
| Total Debt | 50.90M | 50.57M | 53.17M | 46.02M | 48.98M |
| Cash & Equivalents | 49.74M | 75.28M | 41.39M | 83.92M | 119.15M |
| Current Assets | 61.47M | 87.34M | 52.36M | 93.06M | 125.25M |
| Current Liabilities | 58.94M | 49.87M | 37.94M | 36.85M | 19.04M |